Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30
NCLT Chennai Bench dismissed DBS Bank's interim application against Orchid Pharma claiming lease rent during the CIRP period. This removes a potential financial liability for the company.
Apr 11 2026 17:04:00
Orchid Pharma Limited
NCLT Chennai Bench dismissed DBS Bank's application against Orchid Pharma regarding lease rent claims during the CIRP period. This order, dated April 2, 2026, confirmed no financial impact on the company.
Apr 11 2026 17:04:00
Orchid Pharma Ltd - 524372 - Investor Roadshow Scheduled To Be Held On April 10, 2026.
Orchid Pharma's Whole Time Director, Mr. Mridul Dhanuka, will participate in an investor roadshow on April 10, 2026. The group meet, held physically in Gurugram, will not involve sharing any unpublished price sensitive information.
Apr 07 2026 18:04:00
Orchid Pharma Limited
Orchid Pharma to conduct an investor roadshow on April 10, 2026, in Gurugram. Whole Time Director Mr. Mridul Dhanuka will participate, and no unpublished price sensitive information will be shared.
Apr 07 2026 18:04:00
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
Orchid Pharma's long-term bank facilities downgraded to CARE BBB+ (Stable) from CARE A-. The rating action by CARE Ratings Limited affects total facilities of ₹366.50 crore and includes reaffirmation of short-term ratings.
Apr 02 2026 15:04:00
Orchid Pharma Limited
Orchid Pharma's long-term bank facilities rating downgraded by CARE Ratings from CARE A- to CARE BBB+ (stable outlook). This impacts facilities worth ₹366.50 crore, reflecting a revised assessment of the company's financial position.
Apr 02 2026 15:04:00
Read More